# Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging

> **NCT07478705** · NA · NOT_YET_RECRUITING · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 30 (estimated)

## Conditions studied

- Triple Negative Breast Cancer
- Surveillance
- Recurrence
- ctDNA

## Interventions

- **DIAGNOSTIC_TEST:** ctDNA-guided imaging surveillance
- **OTHER:** Standard

## Key facts

- **NCT ID:** NCT07478705
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2029-05-01
- **Final completion:** 2029-05-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07478705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07478705, "Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07478705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*